Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients

Hypercholesterolemia and Type 2 diabetes are well-recognized risk factors for cardiovascular disease, promoted by a condition of subclinical inflammation and a hypercoagulable state. Soluble CD40 ligand (sCD40L), a marker of vascular inflammation, seems to predict vascular damage in patients with Ty...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of endocrinological investigation 2008-07, Vol.31 (7), p.660-665
Hauptverfasser:	Santini, E., Madec, S., Corretti, V., Ferrannini, E., Solini, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Albumins - metabolism Biomarkers - metabolism Blood Pressure CD40 Ligand - blood Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - pathology Endocrinology Female Fluorobenzenes - therapeutic use Homocysteine - blood Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypercholesterolemia - blood Hypercholesterolemia - drug therapy Interleukin-6 - blood Lipids - blood Male Medicine Medicine & Public Health Metabolic Diseases Middle Aged Original Articles Pyrimidines - therapeutic use Rosuvastatin Calcium Simvastatin - therapeutic use Sulfonamides - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!